1. Home
  2. XOMAO vs TDY Comparison

XOMAO vs TDY Comparison

Compare XOMAO & TDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMAO
  • TDY
  • Stock Information
  • Founded
  • XOMAO N/A
  • TDY 1960
  • Country
  • XOMAO United States
  • TDY United States
  • Employees
  • XOMAO 13
  • TDY N/A
  • Industry
  • XOMAO Biotechnology: Pharmaceutical Preparations
  • TDY Industrial Machinery/Components
  • Sector
  • XOMAO Health Care
  • TDY Industrials
  • Exchange
  • XOMAO Nasdaq
  • TDY Nasdaq
  • Market Cap
  • XOMAO N/A
  • TDY N/A
  • IPO Year
  • XOMAO N/A
  • TDY 1999
  • Fundamental
  • Price
  • XOMAO $25.04
  • TDY $484.96
  • Analyst Decision
  • XOMAO
  • TDY Strong Buy
  • Analyst Count
  • XOMAO 0
  • TDY 6
  • Target Price
  • XOMAO N/A
  • TDY $542.50
  • AVG Volume (30 Days)
  • XOMAO N/A
  • TDY 317.4K
  • Earning Date
  • XOMAO N/A
  • TDY 04-23-2025
  • Dividend Yield
  • XOMAO N/A
  • TDY N/A
  • EPS Growth
  • XOMAO N/A
  • TDY N/A
  • EPS
  • XOMAO N/A
  • TDY 17.49
  • Revenue
  • XOMAO N/A
  • TDY $5,769,800,000.00
  • Revenue This Year
  • XOMAO N/A
  • TDY $7.74
  • Revenue Next Year
  • XOMAO N/A
  • TDY $5.37
  • P/E Ratio
  • XOMAO N/A
  • TDY $27.73
  • Revenue Growth
  • XOMAO N/A
  • TDY 2.99
  • 52 Week Low
  • XOMAO N/A
  • TDY $380.63
  • 52 Week High
  • XOMAO N/A
  • TDY $522.50
  • Technical
  • Relative Strength Index (RSI)
  • XOMAO 42.76
  • TDY 58.63
  • Support Level
  • XOMAO $25.04
  • TDY $471.96
  • Resistance Level
  • XOMAO $25.16
  • TDY $488.82
  • Average True Range (ATR)
  • XOMAO 0.08
  • TDY 10.55
  • MACD
  • XOMAO -0.02
  • TDY 3.76
  • Stochastic Oscillator
  • XOMAO 12.28
  • TDY 92.27

About XOMAO AGNC Investment Corp.

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: